Categories
Resources
Your Recalls
Loading...
Get email alerts when new recalls match your interests.
Undeclared Yellow #5
CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.
Out of Specification for Dissolution
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
Product is missing the ingredient TongKat Ali and has additional Rhodiola Rosea
Label error during reprint. Says 1000 mg instead of 1000 mcg on the center front panel of the label.
Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
Failed Impurities/Degradation Specifications